Esperion Therapeutics, Inc. (ESPR)

NASDAQ

$--

(--)

Pre-Market

Esperion Therapeutics, Inc. (ESPR) Live Price Chart

Last updated: ⁦2026-10-21 12:40:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Esperion Therapeutics, Inc. (ESPR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Esperion Therapeutics, Inc. (ESPR) Pre-Market Stock Price

Esperion Therapeutics, Inc. (ESPR) is trading at $-- in pre-market trading as of --, -- from the previous close of $--

Pre-market trading shows how investors are pricing ESPR before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.

Esperion Therapeutics, Inc. (ESPR) 7-Day Stock Price Change

Over the past seven days, Esperion Therapeutics, Inc. (ESPR) moved from $3.17 to $3.18, representing a gain of 0.32% ($0.01).

The stock traded between $3.15 and $3.19 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 27.75 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Esperion Therapeutics, Inc. (ESPR)?

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Esperion Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	294
Exchange	NASDAQ
Company Website	https://www.esperion.com

How to Buy Esperion Therapeutics, Inc. (ESPR) Stock on MEXC

Eligible investors can buy real shares of Esperion Therapeutics, Inc. (ESPR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ESPR and Place Your Order

Open the RealStocks trading page and search for ESPR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Esperion Therapeutics, Inc. (ESPR) stock price today?

Esperion Therapeutics, Inc. (ESPR) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is ESPR stock going up or down today?

As of --, ESPR is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is ESPR pre-market price?

As of --, ESPR is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ESPR after-hours price?

As of --, ESPR is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ESPR stock trading now?

ESPR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ESPR sit relative to its 52-week high and low?

Over the past 52 weeks, ESPR has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Esperion Therapeutics, Inc. in?

Esperion Therapeutics, Inc. (ESPR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Esperion Therapeutics, Inc.'s market capitalization and where is it listed?

Esperion Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ESPR valued in terms of P/E ratio and EPS?

ESPR trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Esperion Therapeutics, Inc. pay a dividend?

Esperion Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.